H.R. 1157House110th Congress (2007-2009)Enacted

Breast Cancer and Environmental Research Act of 2008

Introduced February 16, 2007

Legislative Activity

Stay on top of the latest movement without scrolling through every action

20 earlier actions
Became Law Latest Action

Became Public Law No: 110-354.

October 8, 2008

View full timeline
HouseIntro Referral

Introduced in House

February 16, 2007

HouseIntro Referral

Referred to the House Committee on Energy and Commerce.

February 16, 2007

HouseCommittee

Referred to the Subcommittee on Health.

February 27, 2007

HouseCommittee

Subcommittee Hearings Held.

May 21, 2008

HouseCommittee

Committee Consideration and Mark-up Session Held.

September 23, 2008

HouseCommittee

Ordered to be Reported (Amended) by Voice Vote.

September 23, 2008

HouseCommittee

Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 110-889.

September 25, 2008

HouseCalendars

Placed on the Union Calendar, Calendar No. 574.

September 25, 2008

HouseFloor

Mr. Pallone moved to suspend the rules and pass the bill, as amended.

September 25, 2008 • 4:04 PM

HouseFloor

Considered under suspension of the rules. (consideration: CR H9912-9913)

September 25, 2008 • 4:05 PM

HouseFloor

DEBATE - The House proceeded with forty minutes of debate on H.R. 1157.

September 25, 2008 • 4:05 PM

HouseFloor

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H9912)

September 25, 2008 • 4:13 PM

HouseFloor

On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H9912)

September 25, 2008 • 4:13 PM

HouseFloor

Motion to reconsider laid on the table Agreed to without objection.

September 25, 2008 • 4:13 PM

SenateIntro Referral

Received in the Senate, read twice.

September 26, 2008

SenateFloor

Passed Senate without amendment by Unanimous Consent. (consideration: CR S10018)

September 27, 2008

SenateFloor

Message on Senate action sent to the House.

September 27, 2008

HouseAction

Cleared for White House.

September 27, 2008

President

Presented to President.

September 30, 2008

Became Law

Signed by President.

October 8, 2008

Became Law

Became Public Law No: 110-354.

October 8, 2008

Floor Debate

14 members

What members said about H.R. 1157 on the floor

4 Republicans10 Democrats
Lincoln Diaz-Balart
Rep. Lincoln Diaz-BalartR-FL-21 · Sep 25, 2008

Madam Speaker, I would like to thank my good friend, Mr. Cardoza, the gentleman from California, for the time; and I yield myself such time as I may consume. Madam Speaker, on the opening day of this…

Dennis A. Cardoza
Rep. Dennis A. CardozaD-CA-18 · Sep 25, 2008

Madam Speaker, by direction of the Committee on Rules, I call up House Resolution 1491 and ask for its immediate consideration. Madam Speaker, for the purpose of debate only, I yield the customary 30…

Harry Reid
Sen. Harry ReidD-NV · Sep 27, 2008

Mr. President, I am pleased that both chambers of Congress passed the Breast Cancer and Environmental Research Act this week. Every year, hundreds of thousands of women in this country receive the…

Frank Pallone, Jr.
Rep. Frank Pallone, Jr.D-NJ-6 · Sep 25, 2008

Madam Speaker, I move to suspend the rules and pass the bill (H.R. 1157) to amend the Public Health Service Act to authorize the Director of the National Institute of Environmental Health Sciences to…

Vito Fossella
Rep. Vito FossellaR-NY-13 · May 16, 2007

Madam Speaker, as we return from Mother's Day weekend, I would like to take this opportunity to express my support for H.R. 1157, the Breast Cancer Environmental Research Act, and urge my colleagues…

Show 8 more
Michael E. Capuano
Rep. Michael E. CapuanoD-MA-8 · Jun 5, 2007

Madam Speaker, more than three million American women are currently living with breast cancer. The American Cancer Society estimates that this year, approximately 179,000 new cases of breast cancer…

James P. Moran
Rep. James P. MoranD-VA-8 · May 11, 2007

Madam Speaker, I rise today to honor my mother and all the women in my life. On behalf of these women, I demand answers to the question of what causes breast cancer. This disease has impacted…

Sheila Jackson Lee
Rep. Sheila Jackson LeeD-TX-18 · May 11, 2007

Madam Speaker, I rise today to express my strong support for H.R. 1157, and, in doing so, to honor my mother and all the women in my life. With Mother's Day approaching on Sunday, May 13, I urge my…

Jim Matheson
Rep. Jim MathesonD-UT-2 · May 11, 2007

Madam Speaker, I rise today to urge support for H.R. 1157, the Breast Cancer and Environmental Research Act. What finer tribute to our wives and mothers could we pay during this week before Mother's…

Nita M. Lowey
Rep. Nita M. LoweyD-NY-18 · Sep 25, 2008

Madam Speaker, I rise in support of H.R. 1157, the Breast Cancer and Environmental Research Act. The bill is the product of bipartisan, bicameral negotiations, and in my judgment truly represents a…

James P. Moran
Rep. James P. MoranD-VA-8 · Oct 17, 2007

Mr. Speaker, I rise today to recognize Breast Cancer Awareness Month. Virtually every American has been impacted in one way or another by this deadly disease. More than 3 million women currently live…

Carol Shea-Porter
Rep. Carol Shea-PorterD-NH-1 · May 21, 2007

Madam Speaker, I rise today to urge my colleagues to join me and over 200 other Members in cosponsoring H.R. 1157, the Breast Cancer and Environmental Research Act. With just one more day until…

Nathan Deal
Rep. Nathan DealR-GA-9 · Sep 25, 2008

Madam Speaker, I too rise in support of this legislation and would like to yield such time as she may consume to one of the original sponsors of this legislation, the gentlewoman from North Carolina…

Show 2 more
Sue Wilkins Myrick
Rep. Sue Wilkins MyrickR-NC-9 · Sep 25, 2008

Thank you, Mr. Deal, for yielding. I am very pleased to speak on behalf of this bill and excited that it has come this far, because it is going to further progress breast cancer research as it…

Mary L. Landrieu
Sen. Mary L. LandrieuD-LA · Sep 27, 2008

Mr. President, I ask unanimous consent the Senate proceed to the immediate consideration of H.R. 1157, which was received from the House. I ask unanimous consent the bill be read three times and…

Bill Text

6 versions available

Reading Mode
Latest
Enrolled BillIssued September 29, 2008

One Hundred Tenth Congress of the United States of America

At the Second Session

Begun and held at the City of Washington on Thursday, the third day of January, two thousand and eight

H. R. 1157

AN ACT

To amend the Public Health Service Act to authorize the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer.

1.

Short title

This Act may be cited as the Breast Cancer and Environmental Research Act of 2008.

2.

Expanding collaborative research on breast cancer and the environment

(a)

In general

Subpart 1 of part C of title IV of the Public Health Service Act (42 U.S.C. 285 et seq.) is amended by adding at the end the following:

417F.

Interagency Breast Cancer and Environmental Research Coordinating Committee

(a)

Interagency Breast Cancer and Environmental Research Coordinating Committee

(1)

Establishment

Not later than 6 months after the date of the enactment of this section, the Secretary shall establish a committee, to be known as the Interagency Breast Cancer and Environmental Research Coordinating Committee (in this section referred to as the ‘Committee’).

(2)

Duties

The Committee shall—

(A)

share and coordinate information on existing research activities, and make recommendations to the National Institutes of Health and other Federal agencies regarding how to improve existing research programs, that are related to breast cancer research;

(B)

develop a comprehensive strategy and advise the National Institutes of Health and other Federal agencies in the solicitation of proposals for collaborative, multidisciplinary research, including proposals to evaluate environmental and genomic factors that may be related to the etiology of breast cancer that would—

(i)

result in innovative approaches to study emerging scientific opportunities or eliminate knowledge gaps in research to improve the research portfolio;

(ii)

outline key research questions, methodologies, and knowledge gaps;

(iii)

expand the number of research proposals that involve collaboration between 2 or more national research institutes or national centers, including proposals for Common Fund research described in section 402(b)(7) to improve the research portfolio; and

(iv)

expand the number of collaborative, multidisciplinary, and multi-institutional research grants;

(C)

develop a summary of advances in breast cancer research supported or conducted by Federal agencies relevant to the diagnosis, prevention, and treatment of cancer and other diseases and disorders; and

(D)

not later than 2 years after the date of the establishment of the Committee, make recommendations to the Secretary—

(i)

regarding any appropriate changes to research activities, including recommendations to improve the research portfolio of the National Institutes of Health to ensure that scientifically-based strategic planning is implemented in support of research priorities that impact breast cancer research activities;

(ii)

to ensure that the activities of the National Institutes of Health and other Federal agencies, including the Department of Defense, are free of unnecessary duplication of effort;

(iii)

regarding public participation in decisions relating to breast cancer research to increase the involvement of patient advocacy and community organizations representing a broad geographical area;

(iv)

on how best to disseminate information on breast cancer research progress; and

(v)

on how to expand partnerships between public entities, including Federal agencies, and private entities to expand collaborative, cross-cutting research.

(3)

Rule of construction

For the purposes of the Committee, when focusing on research to evaluate environmental and genomic factors that may be related to the etiology of breast cancer, nothing in this section shall be construed to restrict the Secretary from including other forms of cancer, as appropriate, when doing so may advance research in breast cancer or advance research in other forms of cancer.

(4)

Membership

(A)

In general

The Committee shall be composed of the following voting members:

(i)

Not more than 7 voting Federal representatives as follows:

(I)

The Director of the Centers for Disease Control and Prevention.

(II)

The Director of the National Institutes of Health and the directors of such national research institutes and national centers (which may include the National Institute of Environmental Health Sciences) as the Secretary determines appropriate.

(III)

One representative from the National Cancer Institute Board of Scientific Advisors, appointed by the Director of the National Cancer Institute.

(IV)

The heads of such other agencies of the Department of Health and Human Services as the Secretary determines appropriate.

(V)

Representatives of other Federal agencies that conduct or support cancer research, including the Department of Defense.

(ii)

12 additional voting members appointed under subparagraph (B).

(B)

Additional members

The Committee shall include additional voting members appointed by the Secretary as follows:

(i)

6 members shall be appointed from among scientists, physicians, and other health professionals, who—

(I)

are not officers or employees of the United States;

(II)

represent multiple disciplines, including clinical, basic, and public health sciences;

(III)

represent different geographical regions of the United States;

(IV)

are from practice settings, academia, or other research settings; and

(V)

are experienced in scientific peer review process.

(ii)

6 members shall be appointed from members of the general public, who represent individuals with breast cancer.

(C)

Nonvoting members

The Committee shall include such nonvoting members as the Secretary determines to be appropriate.

(5)

Chairperson

The voting members of the Committee shall select a chairperson from among such members. The selection of a chairperson shall be subject to the approval of the Director of NIH.

(6)

Meetings

The Committee shall meet at the call of the chairperson of the Committee or upon the request of the Director of NIH, but in no case less often than once each year.

(b)

Review

The Secretary shall review the necessity of the Committee in calendar year 2011 and, thereafter, at least once every 2 years.

.

(b)

Authorization of appropriations

For the purpose of carrying out research activities under title IV of the Public Health Service Act, including section 417F of such Act as added by subsection (a), there are authorized to be appropriated $40,000,000 for each of fiscal years 2009 through 2012. Amounts authorized to be appropriated under the preceding sentence shall be in addition to amounts otherwise authorized to be appropriated for such purpose under section 402A of the Public Health Service Act (42 U.S.C. 282a).

Speaker of the House of Representatives.

Vice President of the United States and President of the Senate.